Literature DB >> 26284677

Corrigendum: Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists.

Xiao Hu, Yahong Wang, Ling-Yang Hao, Xikui Liu, Chuck A Lesch, Brian M Sanchez, Jay M Wendling, Rodney W Morgan, Tom D Aicher, Laura L Carter, Peter L Toogood, Gary D Glick.   

Abstract

Entities:  

Year:  2015        PMID： 26284677     DOI： 10.1038/nchembio0915-741b

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  1 in total

1.  Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.

Authors:  Xiao Hu; Yahong Wang; Ling-Yang Hao; Xikui Liu; Chuck A Lesch; Brian M Sanchez; Jay M Wendling; Rodney W Morgan; Tom D Aicher; Laura L Carter; Peter L Toogood; Gary D Glick
Journal:  Nat Chem Biol       Date:  2015-01-05       Impact factor: 15.040
  1 in total
  7 in total

1.  Global Trends in Research of Lipid Metabolism in T lymphocytes From 1985 to 2022: A Bibliometric Analysis.

Authors:  Peng Chen; Cheng Zhong; Shengxi Jin; Yiyin Zhang; Yirun Li; Qiming Xia; Jiaxi Cheng; Xiaoxiao Fan; Hui Lin
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 2.  Th17 cells in the liver: balancing autoimmunity and pathogen defense.

Authors:  Nobuhito Taniki; Nobuhiro Nakamoto; Po-Sung Chu; Masataka Ichikawa; Toshiaki Teratani; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2022-02-24       Impact factor: 11.759

3.  Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357.

Authors:  Christian Harcken; Johanna Csengery; Michael Turner; Lifen Wu; Shuang Liang; Robert Sibley; Steven Brunette; Mark Labadia; Kathleen Hoyt; Anita Wayne; Thomas Wieckowski; Gregg Davis; Mark Panzenbeck; Donald Souza; Stanley Kugler; Donna Terenzio; Delphine Collin; Dustin Smith; Ryan M Fryer; Yin-Chao Tseng; Jörg P Hehn; Kim Fletcher; Robert O Hughes
Journal:  ACS Med Chem Lett       Date:  2021-01-05       Impact factor: 4.345

4.  Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.

Authors:  Xiaohua Xue; Pejman Soroosh; Aimee De Leon-Tabaldo; Rosa Luna-Roman; Marciano Sablad; Natasha Rozenkrants; Jingxue Yu; Glenda Castro; Homayon Banie; Wai-Ping Fung-Leung; Luis Santamaria-Babi; Thomas Schlueter; Michael Albers; Kristi Leonard; Alison L Budelsky; Anne M Fourie
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

5.  Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity.

Authors:  Xingzhe Ma; Enguang Bi; Chunjian Huang; Yong Lu; Gang Xue; Xing Guo; Aibo Wang; Maojie Yang; Jianfei Qian; Chen Dong; Qing Yi
Journal:  J Exp Med       Date:  2018-05-09       Impact factor: 14.307

Review 6.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27

7.  Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.

Authors:  Xiaohua Xue; Aimee De Leon-Tabaldo; Rosa Luna-Roman; Glenda Castro; Michael Albers; Freddy Schoetens; Samuel DePrimo; Damayanthi Devineni; Thomas Wilde; Steve Goldberg; Olaf Kinzel; Thomas Hoffmann; Anne M Fourie; Robin L Thurmond
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.